tiprankstipranks
Advertisement
Advertisement

HK:1276 Stock Latest News

Hengrui Pharma seals global collaboration and licensing deal with Bristol-Myers Squibb
Company AnnouncementsHengrui Pharma seals global collaboration and licensing deal with Bristol-Myers Squibb
12d ago
1276
Hengrui Pharma Sets Formal Remuneration and Evaluation Committee to Bolster Governance
PremiumCompany Announcements
Hengrui Pharma Sets Formal Remuneration and Evaluation Committee to Bolster Governance
24d ago
1276
Hengrui Pharma Sets Nomination Committee to Tighten Board Governance
PremiumCompany Announcements
Hengrui Pharma Sets Nomination Committee to Tighten Board Governance
24d ago
1276
Hengrui Pharma Assumes KiOmed License from Hansoh in Connected Deal
PremiumCompany Announcements
Hengrui Pharma Assumes KiOmed License from Hansoh in Connected Deal
24d ago
1276
Jiangsu Hengrui Sets Detailed Mandate for Board Audit Committee
PremiumCompany Announcements
Jiangsu Hengrui Sets Detailed Mandate for Board Audit Committee
25d ago
1276
Hengrui Pharmaceuticals Posts Double-Digit Profit Growth in Strong Q1 2026
PremiumCompany AnnouncementsHengrui Pharmaceuticals Posts Double-Digit Profit Growth in Strong Q1 2026
1M ago
1276
Jiangsu Hengrui Sets 2025 Final Dividend and Tax Terms for H Shares
Premium
Company Announcements
Jiangsu Hengrui Sets 2025 Final Dividend and Tax Terms for H Shares
1M ago
1276
Jiangsu Hengrui Sets 2025 Final Dividend and Record Date for H Shareholders
Premium
Company Announcements
Jiangsu Hengrui Sets 2025 Final Dividend and Record Date for H Shareholders
1M ago
1276
Hengrui Pharma Shareholders Approve Dividends, Board Changes at 2025 AGM
PremiumCompany Announcements
Hengrui Pharma Shareholders Approve Dividends, Board Changes at 2025 AGM
1M ago
1276
Jiangsu Hengrui Outlines Board Composition and Key Governance Committees
PremiumCompany Announcements
Jiangsu Hengrui Outlines Board Composition and Key Governance Committees
1M ago
1276
Jiangsu Hengrui Schedules Board Meeting to Approve First-Quarter 2026 Results
PremiumCompany Announcements
Jiangsu Hengrui Schedules Board Meeting to Approve First-Quarter 2026 Results
1M ago
1276
Jiangsu Hengrui Pharmaceuticals Publishes 2025 Audited Annual Results
PremiumCompany Announcements
Jiangsu Hengrui Pharmaceuticals Publishes 2025 Audited Annual Results
2M ago
1276
Jiangsu Hengrui Pharmaceuticals Proposes Final 2025 Dividend
PremiumCompany AnnouncementsJiangsu Hengrui Pharmaceuticals Proposes Final 2025 Dividend
2M ago
1276
Hengrui Pharma Sets 2025 AGM to Approve Dividends and 20% Share Issuance Mandate
Premium
Company Announcements
Hengrui Pharma Sets 2025 AGM to Approve Dividends and 20% Share Issuance Mandate
2M ago
1276
Jiangsu Hengrui Boosts Investment in Shanghai Regenelead via RMB750 Million Capital Increase
Premium
Company Announcements
Jiangsu Hengrui Boosts Investment in Shanghai Regenelead via RMB750 Million Capital Increase
2M ago
1276
Hengrui Subsidiary Wins NMPA Nod for New Indication of Innovative HER2 Breast Cancer Drug
PremiumCompany Announcements
Hengrui Subsidiary Wins NMPA Nod for New Indication of Innovative HER2 Breast Cancer Drug
2M ago
1276
Hengrui Pharma Wins New China Approval for Hetrombopag Aplastic Anemia Use
PremiumCompany Announcements
Hengrui Pharma Wins New China Approval for Hetrombopag Aplastic Anemia Use
2M ago
1276
Jiangsu Hengrui sets March 2026 board meeting to approve 2025 results
PremiumCompany Announcements
Jiangsu Hengrui sets March 2026 board meeting to approve 2025 results
2M ago
1276
Jiangsu Hengrui Sets Tenth Board Session with Director Changes and New INED
PremiumCompany Announcements
Jiangsu Hengrui Sets Tenth Board Session with Director Changes and New INED
3M ago
1276
Jiangsu Hengrui Pharma Delays Board Re-election, Extends Current Directors’ Terms
PremiumCompany AnnouncementsJiangsu Hengrui Pharma Delays Board Re-election, Extends Current Directors’ Terms
4M ago
1276
Hengrui Subsidiary Wins NMPA Approval for Innovative Gastric Cancer Biologic
Premium
Company Announcements
Hengrui Subsidiary Wins NMPA Approval for Innovative Gastric Cancer Biologic
5M ago
1276
Hengrui Pharma Shareholders Approve Amendments to Articles of Association
Premium
Company Announcements
Hengrui Pharma Shareholders Approve Amendments to Articles of Association
5M ago
1276

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >